Redken Laboratories Chief Executive Paula Kent Meehan...

Redken Laboratories Chief Executive Paula Kent Meehan and her husband, John, have agreed to boost their offer to buy the company to $34.90 a share, or about $49 million, as part of a tentative settlement of four class-action lawsuits filed in Los Angeles and Delaware. Earlier this month, the Meehans announced that they would pay $34 a share, or about $48 million, for the 1.4 million shares they don’t already own. One of the lawsuits had accused the Meehans of offering a “grossly inadequate price.”